» Articles » PMID: 27194476

Evaluating Cell Reprogramming, Differentiation and Conversion Technologies in Neuroscience

Overview
Specialty Neurology
Date 2016 May 20
PMID 27194476
Citations 150
Authors
Affiliations
Soon will be listed here.
Abstract

The scarcity of live human brain cells for experimental access has for a long time limited our ability to study complex human neurological disorders and elucidate basic neuroscientific mechanisms. A decade ago, the development of methods to reprogramme somatic human cells into induced pluripotent stem cells enabled the in vitro generation of a wide range of neural cells from virtually any human individual. The growth of methods to generate more robust and defined neural cell types through reprogramming and direct conversion into induced neurons has led to the establishment of various human reprogramming-based neural disease models.

Citing Articles

Human neural rosettes secrete bioactive extracellular vesicles enriched in neuronal and glial cellular components.

Herrera Lopez M, Bertone Arolfo M, Remedi M, Gastaldi L, Wilson C, Guendulain G Sci Rep. 2025; 15(1):1987.

PMID: 39814837 PMC: 11736123. DOI: 10.1038/s41598-025-86094-9.


Axodendritic targeting of TAU and MAP2 and microtubule polarization in iPSC-derived versus SH-SY5Y-derived human neurons.

Breuer H, Bell-Simons M, Zempel H Open Life Sci. 2025; 19(1):20221010.

PMID: 39759106 PMC: 11699562. DOI: 10.1515/biol-2022-1010.


Human Tendon-on-a-Chip for Modeling the Myofibroblast Microenvironment in Peritendinous Fibrosis.

Ajalik R, Linares I, Alenchery R, Zhang V, Wright T, Miller B Adv Healthc Mater. 2024; 14(4):e2403116.

PMID: 39544139 PMC: 11804843. DOI: 10.1002/adhm.202403116.


Polyethyleneimine facilitates the growth and electrophysiological characterization of iPSC-derived motor neurons.

Yang M, You D, Liu G, Lu Y, Yang G, OBrien T Sci Rep. 2024; 14(1):26106.

PMID: 39478194 PMC: 11525838. DOI: 10.1038/s41598-024-77710-1.


Biomaterials for Cell Manufacturing.

Miller R, Temenoff J ACS Macro Lett. 2024; 13(11):1521-1530.

PMID: 39466845 PMC: 11580378. DOI: 10.1021/acsmacrolett.4c00634.


References
1.
Lee G, Papapetrou E, Kim H, Chambers S, Tomishima M, Fasano C . Modelling pathogenesis and treatment of familial dysautonomia using patient-specific iPSCs. Nature. 2009; 461(7262):402-6. PMC: 2784695. DOI: 10.1038/nature08320. View

2.
Krencik R, Zhang S . Directed differentiation of functional astroglial subtypes from human pluripotent stem cells. Nat Protoc. 2011; 6(11):1710-7. PMC: 3198813. DOI: 10.1038/nprot.2011.405. View

3.
Farkas L, Huttner W . The cell biology of neural stem and progenitor cells and its significance for their proliferation versus differentiation during mammalian brain development. Curr Opin Cell Biol. 2008; 20(6):707-15. DOI: 10.1016/j.ceb.2008.09.008. View

4.
Israel M, Yuan S, Bardy C, Reyna S, Mu Y, Herrera C . Probing sporadic and familial Alzheimer's disease using induced pluripotent stem cells. Nature. 2012; 482(7384):216-20. PMC: 3338985. DOI: 10.1038/nature10821. View

5.
Suhr S, Chang E, Tjong J, Alcasid N, Perkins G, Goissis M . Mitochondrial rejuvenation after induced pluripotency. PLoS One. 2010; 5(11):e14095. PMC: 2991355. DOI: 10.1371/journal.pone.0014095. View